about
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsMechanisms of chronic JAK-STAT3-SOCS3 signaling in obesityStrategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationMolecular therapies in hepatocellular carcinoma: what can we target?Development of transgenic minipigs with expression of antimorphic human cryptochrome 1The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesisWill targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceCell-autonomous sex determination outside of the gonadA cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesisDietary sugar intake increases liver tumor incidence in female mice.Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma.A model for the epigenetic switch linking inflammation to cell transformation: deterministic and stochastic approachesNon-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patientsCRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.An evaluation of the protective role of vitamin C in reactive oxygen species-induced hepatotoxicity due to hexavalent chromium in vitro and in vivo.BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3KImpact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma.Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivoOntogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophagesTemporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 yearsHCC development is associated to peripheral insulin resistance in a mouse model of NASH.Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records RegisterA novel, dynamic pattern-based analysis of NF-κB binding during the priming phase of liver regeneration reveals switch-like functional regulation of target genes.PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesisCD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis.NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1.Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokinesThe Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer.NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver diseaseLow Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver DiseaseLiver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.
P2860
Q26772302-F3AC613F-00BD-4BBF-A774-B50359A3F16FQ26850181-8C69969F-DE78-4EA1-9602-66E028206C27Q27005375-162604D9-CDB5-441A-95E9-69708102A583Q27025381-BDDB3635-6B96-4B5D-8551-5E724F223422Q27304894-D29A08F4-0D77-4C02-B624-FA5A3E2E0ED0Q27319729-594F3077-E62A-4275-BEEF-13370BA4BA07Q28078957-116D14EF-66D8-4D35-9582-6438F6143BABQ28468601-5401BF19-53A6-42A0-A5DA-91242B403F82Q28681979-68209B68-41A1-4FCA-8574-2921B7E632B8Q28818626-950259FC-9D3A-4D3A-B26D-A2F164910E8FQ30277250-6A0A654F-A2A6-4D20-A04E-59E97A45B78FQ30993390-82128D6D-5C3C-4947-846B-62ED6997416AQ31151086-E43E924D-B80A-419C-B8F7-4C1F6E65923EQ33716459-ECFDFC5A-0772-41AF-BD3D-581711AF0062Q33734225-925100B2-EE9D-451C-960F-20A74769FAE7Q33765935-8489071F-E5C9-478C-A053-6D00C26A368FQ33805021-24F55093-18A7-4E71-9963-DAE800F063B3Q33838482-F8239A5E-7D20-40BB-A680-5ED856042C53Q34072173-0115A2E5-6A99-495B-A14C-7656373FFEB5Q34413462-2D9E6F58-09E3-4D4C-B9D1-B0E99402F225Q34511085-C7B5BEF7-D93F-4F50-A172-01ED7207C21DQ34634316-BD34C741-6777-429E-B892-D0A046C80B3DQ35000376-4259B512-673E-4006-9E5C-E9956826C29CQ35047746-CFBC574F-C6D1-46C8-B594-9FA08CE1EF57Q35172679-C48D0EB5-F0B8-4C94-B1A6-CDB60A0992FAQ35573118-F3B6DF64-52A9-4980-BA4F-668680417855Q35718170-31E80DFA-705A-44FE-AE6A-CF67B9B5ACD6Q35832384-3FB1CB8D-8084-4EC1-91D1-9DEC27D34C82Q35855499-12597664-8207-43E1-A0A1-3DB1A233EBB4Q36080679-24BADD49-8523-4133-BF37-A9917092D471Q36140475-654A0108-911D-40EA-B126-4DACCC68C604Q36194685-4CB5E80F-D2C9-48B7-A7E2-5BC2BFE03B69Q36295444-770EF09D-8E14-4DC7-A257-56228DDAB7B4Q36320944-E89FAEFB-037D-45C8-9B09-639FA4B90E05Q36355874-BB887CAF-5EB2-420F-A680-7A074E34B4A7Q36673866-28BD0F37-4661-4203-9875-DD00BEE5008FQ36705993-E382586E-D537-4E4E-A12A-7CB5D3AD8A8CQ36723148-4D33A2BC-79D3-4757-9B2A-420D000684CDQ36743546-4F1C1A2E-3888-448B-B4F4-E6CB6746DF19Q36927013-3462E15E-1503-48A2-B8FF-4D09C82E079D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Obesity, inflammation, and liver cancer.
@en
Obesity, inflammation, and liver cancer.
@nl
type
label
Obesity, inflammation, and liver cancer.
@en
Obesity, inflammation, and liver cancer.
@nl
prefLabel
Obesity, inflammation, and liver cancer.
@en
Obesity, inflammation, and liver cancer.
@nl
P2860
P1476
Obesity, inflammation, and liver cancer.
@en
P2093
Beicheng Sun
P2860
P304
P356
10.1016/J.JHEP.2011.09.020
P577
2011-11-25T00:00:00Z